Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Human Liver Model Market to reach USD 4.36 billion by 2026

Global Human Liver Model Market Size by Type (Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting) and Regional Forecasts 2019-2026

Product Code: HALMD_38311735
Publish Date: 17-02-2020
Page: 200

Global Human Liver Model Market valued approximately USD 1.55 billion in 2018 is anticipated to grow with a healthy growth rate of more than 13.8% over the forecast period 2019-2026. Human liver models offer a virtual environment that mimics the molecular processes of a liver factory and helps to understand molecular interactions to network dynamics and whole organ functions. Also, the human liver models are gaining popularity owing to its benefits such as these models are more accurate than the animal models. The advent of the organoid technology is considered as a major trend that has led to develop innovation ways to treat liver diseases. The key factors that are the driving force in the growth of this market include growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing want for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure. However, concerns related to the incorporation of organoids into existing workflows is the major factors that impede the growth of global human liver model market.
The regional analysis of Global Human Liver Model Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America holds the leading position in terms of revenue in human liver model market. Factors such as growing awareness about organoids, presence of well-established life sciences industry and growing demand for tissue culture-based clinical diagnostics are some key factors driving the growth of the North America. Whereas, Asia-Pacific is expected to emerge as a lucrative region for global human liver model market. The growth of the Asia-Pacific region is supplemented by the rapid development of healthcare infrastructure coupled with increasing healthcare expenditure across the region.

Major manufacturers involved in this market are-
Ascendance Bio
CN Bio
Cyfuse Biomedical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Liver Organoids
2D Models
Animal Models
3D Bioprinting

By Regions:
North America
Asia Pacific
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Human Liver Model in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Human Liver Model Market, by Type, 2017-2026 (USD Billion)
1.2.2. Human Liver Model Market, by Region, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Liver Model Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Liver Model Market Dynamics
3.1. Human Liver Model Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Human Liver Model Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Human Liver Model Market, by Type
5.1. Market Snapshot
5.2. Global Human Liver Model Market by Type, Performance – Potential Analysis
5.3. Global Human Liver Model Market Estimates & Forecasts by Type, 2016-2026 (USD Billion)
5.4. Human Liver Model Market, Sub Segment Analysis
5.4.1. Liver Organoids
5.4.2. Liver on a Chip
5.4.3. 2D Models
5.4.4. 3D Bioprinting
5.4.5. Animal Models
Chapter 6. Global Human Liver Model Market, Regional Analysis
6.1. Human Liver Model Market, Regional Market Snapshot
6.2. North America Human Liver Model Market
6.2.1. U.S. Human Liver Model Market Type breakdown estimates & forecasts, 2016-2026
6.2.2. Canada Human Liver Model Market
6.3. Europe Human Liver Model Market Snapshot
6.3.1. U.K. Human Liver Model Market
6.3.2. Germany Human Liver Model Market
6.3.3. Rest of Europe Human Liver Model Market
6.4. Asia-Pacific Human Liver Model Market Snapshot
6.4.1. China Human Liver Model Market
6.4.2. India Human Liver Model Market
6.4.3. Japan Human Liver Model Market
6.4.4. Rest of Asia Pacific Human Liver Model Market
6.5. Latin America Human Liver Model Market Snapshot
6.5.1. Brazil Human Liver Model Market
6.5.2. Mexico Human Liver Model Market
6.6. Rest of The World Human Liver Model Market
Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Emulate Overview Financial (Subject to Data Availability) Product Summary Recent Developments
7.2.2. Ascendance Bio
7.2.3. HIREL
7.2.4. CN Bio
7.2.5. Organovo
7.2.6. Cyfuse Biomedical
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Primary Research Sources:

  • Interview conducted with raw material suppliers & manufacturers.
  • Interview conducted with manufacturers, suppliers & distributors, researchers, & representatives of regulatory bodies.
  • Interview conducted with market players, industry experts, & independent consultants.
  • Secondary Research Sources:
  • Purchased Database: D&B Hoovers, Bloomberg, Inc., Business Information Industry Association, NAICS Association.
  • Internal Database: White papers, Certified Publications, Articles by Recognized Authors and Regulatory Bodies.
  • Government Databases: Food and Agriculture Organization (FAO), European Industrial Hemp Association (EIHA), World Health Organization (WHO), Food and Drug Administration (FDA), International Telecommunication Union (ITU), United States Department of Agriculture (USDA), International organization of Motor Vehicle Manufacturers (OICA).

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now